• Blog Post

Webinar: Overcoming Barriers to Medication Adherence Amid COVID-19 and Beyond

Apr 28th, 2021

Addressing the Challenges of Medication Adherence Amid COVID-19

A recent survey by the Centers for Disease Control and Prevention found that the proportion of U.S. adults with symptoms of anxiety and/or depression has tripled since the start of the pandemic. With that rise comes many challenges, including a greater need to ensure proper access to care and keep consumers on their medications. 

Genoa Healthcare’s Lindsey Hall, PharmD, BCACP, senior director of clinical programs, design and strategy and Jenn Heath, BCACP clinical quality manager, recently hosted a webinar about overcoming barriers to medication adherence during the pandemic and beyond. Below you can watch the webinar, which addresses: 

  • An update on the COVID-19 vaccine
  • Challenges and impacts related to the pandemic
  • Medication adherence amid COVID-19

To learn more about how pharmacy services can help you and your consumers, contact us today

Additional Resources

  • Convalescent plasma for treatment of COVID-19: Clinical studies are underway and while there is an Emergency Use Authorization (EUA) for use of convalescent plasma, observational studies have shown mixed results. The CDC recommends anyone who received convalescent plasma delay COVID-19 vaccination for 90 days. Click here to read more.
  • Visit https://www.genoahealthcare.com/covid19 or email [email protected] for more information.

Recent Posts

  • Blog Post
Partnering with ACT teams to make an even bigger impact

Genoa Healthcare® pharmacist Julie R. has seen firsthand the impact that severe and persistent mental illness can have on a person. For one of her consumers living with schizophrenia, the...

  • Blog Post
  • Webinar
For consumers living with Tardive Dyskinesia, Genoa Healthcare’s Clinical Assistance Program offers personalized support

Tardive Dyskinesia – a neurological disorder linked to prolonged use of antipsychotic medications – impacts over 600,000 individuals each year. Did you know that 50% of consumers taking TD medication...

  • Blog Post
A foundation to build on: 3 ways an engaged pharmacy partner helps you deliver whole-person health

A recent survey found that nearly 60% of behavioral health, primary care and complex care providers reported that their organization currently offered or had plans to begin offering integrated care...

  • Clinical Insights
  • Webinar
Understanding Tardive Dyskinesia: What you need to know

Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually. Wondering what this means for the people you serve? Genoa...